JEFFREY W. SHERMAN - Director at Larimar Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
LRMR on Nasdaq
All Insider Reports
All Insider Reports

JEFFREY W. SHERMAN - trading volume in the past year for Larimar Therapeutics, Inc.

Holdings reported by JEFFREY W. SHERMAN for Larimar Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 5,000 $25,000 $5.00 27 Feb 2026 Direct
Stock Option (Right to Buy) 19,000 13 May 2025 Direct Common Stock

Transactions reported by JEFFREY W. SHERMAN for Larimar Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.